1027 lines
16 KiB
HTML
1027 lines
16 KiB
HTML
<!doctype html public "-//W3C//DTD HTML 4.01 Transitional//EN">
|
|
<html lang="en">
|
|
|
|
<head>
|
|
|
|
<title>NLM Classification, 5th Edition Additions and Changes List 4. NLM Technical Bulletin. Jan-Feb 1999</title>
|
|
<meta name="DC.Subject.IssueCover" content="/pubs/techbull/jf99/jf99_technote.html" />
|
|
|
|
<meta name="DC.Subject.IssueNum" content="309" />
|
|
<!--do not remove!! nlm survey script - contact wwwnlm@nlm.nih.gov with questions -->
|
|
<script src="/share/scripts/survey.js" type="text/javascript" language="javascript"></script>
|
|
<meta name="DC.Subject.Keyword" content="Animal" />
|
|
<meta name="DC.Subject.Keyword" content="Book" />
|
|
<meta name="DC.Subject.Keyword" content="Cataloging" />
|
|
<meta name="DC.Subject.Keyword" content="Edition" />
|
|
<meta name="DC.Subject.Keyword" content="Genetics" />
|
|
<meta name="DC.Subject.Keyword" content="Hands on" />
|
|
<meta name="DC.Subject.Keyword" content="MedlinePlus" />
|
|
<meta name="DC.Subject.Keyword" content="MeSH Terms" />
|
|
<meta name="DC.Subject.Keyword" content="NLM Classification" />
|
|
<meta name="DC.Subject.Keyword" content="NLM Exhibition" />
|
|
<meta name="DC.Subject.Keyword" content="OLDMEDLINE" />
|
|
<meta name="DC.Subject.Keyword" content="PubMed" />
|
|
<meta name="DC.Subject.Keyword" content="Subset" />
|
|
<meta name="DC.Subject.Keyword" content="Systematic Reviews" />
|
|
<meta name="DC.Subject.Keyword" content="Update" />
|
|
</head>
|
|
|
|
<body bgcolor="#f0f0f0" link="#083184" vlink="#960044"><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MT6MLL" height="0" width="0" style="display:none;visibility:hidden" title="googletagmanager"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-MT6MLL');</script>
|
|
<style type="text/css">
|
|
#skip, .skip, .skipnavigation {
|
|
position:absolute;
|
|
left:0px;
|
|
top:-500px;
|
|
width:1px;
|
|
height:1px;
|
|
overflow:hidden;
|
|
}
|
|
</style>
|
|
<div class="skipnavigation"><a title="Skip the navigation on this page" href="#skipnav" class="skipnavigation">Skip Navigation Bar</a></div>
|
|
|
|
<a href="/nlmhome.html"><img src="/pubs/techbull/tb_graphics/tbhead4.gif" border="0" alt="NLM Technical Bulletin"/></a>
|
|
|
|
<h3><em>NLM Technical Bulletin.</em> 1999 January-February; 306</h3>
|
|
|
|
|
|
|
|
<hr />
|
|
|
|
<a id="skipnav" name="skipnav"></a>
|
|
<table border="0" cellspacing="0" cellpadding="10">
|
|
|
|
<tr>
|
|
|
|
<td valign=top bgcolor="#CB9966" width="140">
|
|
|
|
<hr />
|
|
|
|
<center><strong>In This Issue:</strong></center>
|
|
|
|
<hr />
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_technote.html">Technical Notes</a> - e1
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<img src="/pubs/techbull/tb_graphics/blutri.gif" alt="dot" height="10" width="10" />NLM Classification, 5th Edition Additions and Changes List 4 - e2
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_subset.html">PubMed: Searching Using Subsets</a> - e3
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_oldmedline.html">OLDMEDLINE Database Moves Back in Time</a> - e4
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_pubmed.html">Hands On: PubMed Update</a> - e5
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_medlineplus.html">MEDLINE<em>plus</em></a> - e6
|
|
|
|
</p>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/current_issue.html">Current Issue</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/tb.html">Home</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/back_issues.html">Back Issues</a></strong></center>
|
|
|
|
<hr />
|
|
<center><strong><a href="/pubs/techbull/new_index.html">Index</a></strong></center>
|
|
<hr />
|
|
</td>
|
|
|
|
|
|
|
|
<td valign=top width="440">
|
|
|
|
|
|
|
|
<center><h2>NLM Classification, 5th Edition</h2></center>
|
|
|
|
<center><h2>Additions and Changes List 4</h2></center>
|
|
|
|
|
|
|
|
|
|
|
|
<p>
|
|
|
|
The following additions to the Index of the fifth edition of the NLM Classification have been made since the issuance of Additions and Changes, List 3, announced in the November-December 1998 issue of the <em>NLM Technical Bulletin</em>. The Cataloging Section conducted a systematic review of the new 1999 MeSH terms to determine the need for additions and changes to the classification. The resulting additions to the Index are presented in chart form below. There are no significant changes to the Main Schedules or the Index; minor changes such as adding subindexes under specific existing Index terms are not listed.
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<center><strong><a name="addindex" id="addindex">Additions in the Index</a></strong></center>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Botrytis QW 180.5.D38
|
|
|
|
<dd>Botany QK 625.M7</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Calcium Signaling
|
|
|
|
<dd>Cytology QH 601</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Calcium QV 276, etc.; Calcium-Binding Proteins </dd>
|
|
|
|
<dd> QU 55; Calcium Channels QH 603.I54; </dd>
|
|
|
|
<dd> Calmodulin QU 55</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Cell Death QH 671
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cell Survival
|
|
|
|
<dd>Effect of physical and chemical agents QH 650-659</dd>
|
|
|
|
<dd>Metabolism QH 634.5</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Cell Aging QH 608, etc.; Cell Death QH 671; </dd>
|
|
|
|
<dd> Cell Physiology QH 631</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Chondrogenesis WE 300
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Choroidal Neovascularization WW 245
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Cisapride
|
|
|
|
<dd>As a gastrointestinal agent QV 66</dd>
|
|
|
|
<dd>Biochemistry QU 62</dd>
|
|
|
|
<dd>Used in the treatment of particular diseases, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Collected Correspondence
|
|
|
|
<dd>Physicians and specialists of medically related fields
|
|
|
|
<dl>
|
|
|
|
<dd>Collective WZ 112-150</dd>
|
|
|
|
<dd>Individual WZ 100</dd>
|
|
|
|
</dl>
|
|
</dd>
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Confined Spaces
|
|
|
|
<dd>Related to occupational health WA 400-495</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
<dd>See also Air Pollutants, Occupational WA 450; Ecological</dd>
|
|
|
|
<dd> Systems, Closed WD 756; Ventilation WA 770, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Dermis WR 101
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Education, Distance
|
|
|
|
<dd>(Form number 18 in any NLM schedule where applicable)</dd>
|
|
|
|
<dd>In particular subjects, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Enterocolitis, Necrotizing WI 420
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Epstein-Barr Virus Infections WC 571
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Exhibitions
|
|
|
|
<dd>(Form numbers 27-28 in any NLM schedule where applicable)</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Fitness Centers QT 255
|
|
|
|
<dd>See also Recreation QT 250, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Genetic Predisposition to Disease QZ 50
|
|
|
|
<dd>To specific diseases, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Ginkgo biloba
|
|
|
|
<dd>As a medicinal plant QV 766</dd>
|
|
|
|
<dd>Botany QK 494.5.G48</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Heavy Ions WN 415-450
|
|
|
|
<dd>General physics QC 702.7.H42</dd>
|
|
|
|
<dd>Health physics WN 110</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Heteroptera QX 503
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Hormone Replacement Therapy WK 190
|
|
|
|
<dd>For specific disorders, with the disorder</dd>
|
|
|
|
<dd>See also Estrogen Replacement Therapy WP 522; and </dd>
|
|
|
|
<dd> names of specific hormones</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Hospitalists WX 203
|
|
|
|
<dd>See also names of specific types of hospitals</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Hydrogels
|
|
|
|
<dd>As biocompatible materials (General) QT 37.5.P7</dd>
|
|
|
|
<dd>As dosage form QV 785</dd>
|
|
|
|
<dd>Biochemisty QU 133</dd>
|
|
|
|
<dd>Used for special purposes, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Hyperhomocysteinemia WD 205.5.A5
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Internet TK 5105.875.I57
|
|
|
|
<dd>In medicine (General) W 26.5</dd>
|
|
|
|
<dd>In other special fields (Form number 26.5 in any NLM</dd>
|
|
|
|
<dd> schedule where applicable)</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Journalism PN 4699-5650
|
|
|
|
<dd>In medicine (General) WZ 345</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Latex Allergy
|
|
|
|
<dd>General WD 300</dd>
|
|
|
|
<dd>Contact dermatitis WR 175</dd>
|
|
|
|
<dd>Occupational dermatitis WR 600</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Lithiasis QZ 180
|
|
|
|
<dd>Localized, by site</dd>
|
|
|
|
<dd>See also Bladder Calculi WJ 500; Calculi QZ 180, etc.;</dd>
|
|
|
|
<dd> Cholelithiasis WI 755; </dd>
|
|
|
|
<dd> Common Bile Duct Calculi WI 755;</dd>
|
|
|
|
<dd> Kidney Calculi WJ 356; Salivary Duct Calculi WI 230;</dd>
|
|
|
|
<dd> Ureteral Calculi WJ 400; Urinary Calculi WJ 140</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Manipulation, Spinal WB 535
|
|
|
|
<dd>Used for treatment of particular disorders, with the disorder</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Medical Savings Accounts
|
|
|
|
<dd>Economic aspects W 74</dd>
|
|
|
|
<dd>Related to health insurance W 100-275</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Medicare Part A WT 31
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Medicare Part B WT 31
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Medicare Part C WT 31
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Membrane Lipids QU 85
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Molecular Motors
|
|
|
|
<dd>General QU 55</dd>
|
|
|
|
<dd>See also Cytoskeletal Proteins QU 55; </dd>
|
|
|
|
<dd> Cytoskeleton QH 603.C96</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Myofunctional Therapy
|
|
|
|
<dd>In dentistry (General) WU 140-140.5</dd>
|
|
|
|
<dd>For particular diseases, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Needs Assessment W 84.3
|
|
|
|
<dd>In special areas, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Neoadjuvant Therapy QZ 266-269
|
|
|
|
<dd>For particular diseases, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Neurogenic Inflammation
|
|
|
|
<dd>General physiopathology WL 500</dd>
|
|
|
|
<dd>In particular diseases, with the disease</dd>
|
|
|
|
<dd>Localized, by site</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Nurses' Instruction
|
|
|
|
<dd>On specific topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Orbital Implants WW 358
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Organisms, Transgenic QH 442.6
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Osteoarthritis, Knee WE 870
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Outsourced Services
|
|
|
|
<dd>In medicine (General) W 74</dd>
|
|
|
|
<dd>Other topics, class by subject if specific; if general, in </dd>
|
|
|
|
<dd> economics number where available</dd>
|
|
|
|
<dd>See also Contract Services W 74, etc.</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Oxalic Acid
|
|
|
|
<dd>Biochemistry QU 98</dd>
|
|
|
|
<dd>Toxicology QV 632</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Pericytes WG 700
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Peroxisome Proliferators
|
|
|
|
<dd>As carcinogens (General) QZ 202</dd>
|
|
|
|
<dd>Causing liver neoplasms WI 735</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Personnel Downsizing HF 5549.5.D55
|
|
|
|
<dd>Hospitals WX 159</dd>
|
|
|
|
<dd>Nursing WY 30</dd>
|
|
|
|
<dd>In special areas, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Phanerochaete QW 180.5.B2
|
|
|
|
<dd>Botany QK 629.C785</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Photoreceptors, Invertebrate QL 364
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Photoreceptors, Vertebrate WW 270
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Polygenic Inheritance
|
|
|
|
<dd>Medical genetics (General) QZ 50</dd>
|
|
|
|
<dd>Of a particular disease, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Practice Management
|
|
|
|
<dd>Dental see Practice Management, Dental WU 77-79</dd>
|
|
|
|
<dd>General W 80</dd>
|
|
|
|
<dd>Medical see Practice Management, Medical W 80</dd>
|
|
|
|
<dd>Veterinary SF 756.4</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Proxy
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Radiotherapy, Conformal WN 250.5.R2
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Raptors
|
|
|
|
<dd>Diseases SF 994.5</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Rats, Long-Evans
|
|
|
|
<dd>As laboratory animals QY 60.R6</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Recovery of Function
|
|
|
|
<dd>In brain injuries WL 354, etc.</dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Reduviidae QX 503
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Risk Adjustment
|
|
|
|
<dd>Used in evaluation of quality of health care
|
|
|
|
<dl>
|
|
|
|
<dd>General W 84</dd>
|
|
|
|
<dd>Hospitals WX 153</dd>
|
|
|
|
</dl></dd>
|
|
|
|
<dd>Special topics, by subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Risk Sharing, Financial
|
|
|
|
<dd>General W 74</dd>
|
|
|
|
<dd>Other topics, class by subject if specific; if general, </dd>
|
|
|
|
<dd> in economics number where available</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Self Efficacy BF 637.S38
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Sertraline
|
|
|
|
<dd>As an antidepressive agent QV 77.5</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Shoulder Pain WE 810
|
|
|
|
<p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Silicone Gels
|
|
|
|
<dd>Used in breast implants WP 910</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Sirenia QL 737.S6-737.S63
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Smoking Cessation WM 290
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Tobacco Use Cessation WM 290
|
|
|
|
</p>
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Union Lists
|
|
|
|
<dd>Books or general Z 695.83</dd>
|
|
|
|
<dd>Nonbook material Z 6851</dd>
|
|
|
|
<dd>Serials Z 6945</dd>
|
|
|
|
<dd>On particular subjects, in bibliography number for the subject</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Venous Thrombosis WG 610
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dt>Ventricular Remodeling
|
|
|
|
<dd>General WG 202</dd>
|
|
|
|
<dd>Following a particular disease, with the disease</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
<p>
|
|
|
|
Vitreous Detachment WW 250
|
|
|
|
</p>
|
|
|
|
|
|
|
|
|
|
|
|
<br /><br />
|
|
|
|
|
|
|
|
|
|
|
|
<dl>
|
|
|
|
<dd><em>--prepared by Wen-Min Kao</em></dd>
|
|
|
|
<dd>Technical Services Division</dd>
|
|
|
|
</dl>
|
|
|
|
|
|
|
|
|
|
|
|
</td>
|
|
|
|
</tr>
|
|
|
|
<tr><td valign=top bgcolor="#CB9966" width="140">
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_subset.html">Next article</a>
|
|
|
|
<p>
|
|
|
|
<a href="/pubs/techbull/jf99/jf99_class.html">Table of contents</a>
|
|
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/tb.html">Home</a>
|
|
</p>
|
|
|
|
<p>
|
|
<a href="/pubs/techbull/new_index.html">Index</a>
|
|
</p>
|
|
</td>
|
|
</tr>
|
|
</table>
|
|
|
|
<br />
|
|
<hr />
|
|
<!-- BEGIN NLM FOOTER -->
|
|
<center>
|
|
<font size="2" face="helvetica, arial"><a href="/nlmhome.html">U.S. National Library of Medicine</a>, 8600 Rockville Pike, Bethesda, MD 20894<br /><a href="http://www.nih.gov/">National Institutes of Health</a>, <a href="//www.hhs.gov/">Department of Health & Human Services</a><br /><a href="/copyright.html">Copyright</a>, <a href="/privacy.html">Privacy</a>, <a href="/accessibility.html">Accessibility</a>, <a href="http://www.nih.gov/icd/od/foia/index.htm">Freedom of Information Act (FOIA)</a><br/><a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html">HHS Vulnerability Disclosure</a>
|
|
<br />
|
|
<!-- ******************MODIFY "LAST UPDATED" ******************* -->
|
|
Last updated: 11 April 2012
|
|
</font>
|
|
</center>
|
|
|
|
<!-- END NLM FOOTER -->
|
|
<!-- ******************MODIFY EXPDATE AND EMAIL BELOW****************** -->
|
|
<!-- EXPDATE="2015-03-20" -->
|
|
<!-- EMAIL="nlmtechbull@mail.nlm.nih.gov" -->
|
|
<script src="//assets.nlm.nih.gov/jquery/jquery-latest.min.js"></script><script src="/core/nlm-notifyExternal/1.0/nlm-notifyExternal.min.js"></script></body>
|
|
</html>
|
|
|